NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The National Register of Antipsychotic Medication in Pregnancy (NRAMP)
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)

NCT00686946

UnknownN/A

Sponsor: The Alfred

Conditions: Pregnancy, Mental Disorders

Countries: Australia

The National Register of Antipsychotic Medication in Pregnancy (NRAMP)is an observational, nationwide study involving women of child-bearing age who take antipsychotic medication during pregnancy. It follows the pathway of mother and baby during pregnancy and for the first 12 months of the baby's life, in order to develop evidence-based guidelines for the best use and effect of antipsychotic medication during pregnancy, thereby informing clinical treating teams with regard to the management of their patients in this vulnerable population group. The investigators hypothesize that the provision of such evidence-based guidelines will improve the management and outcomes for mother and baby during pregnancy, birth and the postnatal phase, providing a positive impact on maternal and child health and wellbeing for present and future generations.

Eligibility overview

Sex: FEMALE

Age: 18 Years to 50 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Women who take antipsychotic medication during pregnancy
* Women who are pregnant or have had a baby in the last 12 months
* Women who are living in Australia
* Women who are able to provide informed consent

Exclusion Criteria:

* Women who do not take antipsychotic medication during pregnancy
* Women who are not pregnant, or have not had a baby in the last 12 months
* Women who are unable to provide informed consent
Locations (1)
  • Melbourne, Victoria, Australia